Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), whic…
Biotechnology
US, Florham Park [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Cellectar Biosciences, Inc. has no acquisition track records yet.
M&A Deals · History
Cellectar Biosciences, Inc. has no acquisition track records yet.